Ledger.Open graph →
SEC Form D · Amendment · filed April 1, 2020

Ralexar Therapeutics, Inc

Offering
$6.0M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Encinitas, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Daniel Freed · Chicago, ILDirectorStephen Tullman · Wayne, PAExec · DirectorTodd B. Allen · Roswell, GADirectorDavid Pfeiffer · Wayne, PAExec · DirectorThomas J. Powell · Reno, NVExec · DirectorJohn G. Jordan · Austin, TXDirectorJason J. Hong · New York, NYDirectorGeorge P. Rauch · Dallas, TXExec · DirectorMark Heaney · Dubai, C0DirectorMatthew B. Bass · New York, NYExec · DirectorSabrina Foster · Grand Cayman, Cayman IslandsDirectorCristobal K. Conde · London, United KingdomDirectorPatrick Porter · New Bern, NCExec · DirectorSomasundaram Subramaniam · New York, NYDirectorNeal Walker · Wayne, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗